Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Parkinson's Disease
Parkinson's Disease
AskBio receives FDA Fast Track and MHRA Innovation Passport Designations for AB-1005 Investigational GDNF Gene Therapy for Parkinson’s Disease
Drugs.com
Thu, 07/11/24 - 10:55 pm
Bayer
AskBio
FDA
AB-1005
Parkinson's Disease
fast track status
FDA Again Hits AbbVie Parkinson’s Treatment With Complete Response Letter
BioSpace
Tue, 06/25/24 - 11:29 am
AbbVie
Parkinson's Disease
FDA
ABBV-951
How Roche is finding better ways to diagnose brain conditions like Alzheimer’s and Parkinson’s disease
Pharma Voice
Tue, 06/18/24 - 11:34 am
Roche
biomarkers
Alzheimer's disease
Parkinson's Disease
R&D
US Congress passes bill to end Parkinson’s disease
Pharmaphorum
Thu, 05/30/24 - 11:08 am
Senate
congress
Parkinson's Disease
legislation
Lucy Therapeutics secures $12.5m for neurological treatment development
Pharmaceutical Business Review
Wed, 05/29/24 - 11:49 am
Lucy Therapeutics
funding
Alzheimer's disease
Parkinson's Disease
FDA competition seeks digital endpoints for Parkinson’s
Pharmaphorum
Tue, 05/21/24 - 11:01 am
FDA
digital health
Parkinson's Disease
AbbVie, NeuroDerm Heat Up Levodopa Competition with New Data at AAN24
BioSpace
Mon, 04/22/24 - 11:40 am
AbbVie
NeuroDerm
Levodopa
Parkinson's Disease
AAN
AAN 2024: Pharma Two B’s P2B001 shows promise in early PD
Clinical Trials Arena
Sun, 04/21/24 - 10:48 pm
AAN
Pharma Two B
P2B001
Parkinson's Disease
clinical trials
AI Identifies New Potential Treatments For Parkinson’s Disease
Forbes
Thu, 04/18/24 - 11:23 am
artificial intelligence
drug discovery
Parkinson's Disease
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
BioPharma Dive
Thu, 04/18/24 - 11:09 am
Cerevel Therapeutics
Parkinson's Disease
tavapadon
Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop
BioSpace
Wed, 04/17/24 - 11:23 am
SAGE Therapeutics
clinical trials
Parkinson's Disease
dalzanemdor
AbbVie-backed effort spotlights night symptoms of Parkinson’s
Medical Marketing and Media
Thu, 04/11/24 - 10:15 pm
Parkinson's Disease
AbbVie
public awareness
FDA swats away Supernus’ Parkinson’s disease infusion pump for 3rd time
Fierce Pharma
Mon, 04/8/24 - 11:07 am
Medtech
FDA
Supernus
Parkinson's Disease
Parkinson’s disease may be helped by GLP-1 drug, new study finds
Stat
Wed, 04/3/24 - 10:41 pm
GLP-1 agonist
Parkinson's Disease
lixisenatide
Photopharmics kickstarts phototherapy trial for Parkinson’s disease
Clinical Trials Arena
Thu, 03/28/24 - 11:15 am
Photopharmics
phototherapy
Medtech
clinical trials
Parkinson's Disease
Cure Ventures backs a cell therapy startup targeting Parkinson’s
BioPharma Dive
Thu, 02/29/24 - 06:58 pm
Kenai Therapeutics
cell therapy
Parkinson's Disease
funding
Cure Ventures
AbbVie introduces Produodopa for advanced Parkinson’s in EU
Pharmaceutical Business Review
Wed, 01/10/24 - 09:31 am
AbbVie
Produodopa
Parkinson's Disease
Europe
Bayer's AskBio checks off another early win for gene therapy platform with Parkinson's safety data
Fierce Biotech
Thu, 01/4/24 - 10:12 am
Bayer
AskBio
gene therapy
Parkinson's Disease
Enrollment starts in trial of AI-powered Parkinson’s therapy
Pharmaphorum
Fri, 12/15/23 - 09:39 am
Parkinson's Disease
Newel Health
clinical trials
digital therapeutics
Medtech
artificial intelligence
Potential FDA approval for Supernus’s SPN-830 in Parkinson’s but challenges remain
Clinical Trials Arena
Mon, 10/16/23 - 10:18 am
Supernus
SPN-830
Parkinson's Disease
FDA
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »